Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Covid-19 vaccines are available across the United States. Vaccines represent the best protection against sever illness and ...

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a ...

The newest, updated Covid-19 vaccines are now FDA-approved and available, including the mRNA ones from Pfizer-BioNTech and ...

The US Food and Drug Administration (FDA) has granted emergency use authorization for Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 formula), to be used in patients 12 years of age and older. The ...

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and ...

In Australia, our process differs slightly and tends to take a little longer. The TGA’s website indicates applications for ...